NCT02085265 Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients Status TERMINATED Phase PHASE2
NCT02080364 Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease Status TERMINATED Phase PHASE3
NCT02079909 Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202) Status COMPLETED Phase PHASE2
NCT02079246 Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT02078310 Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia Status COMPLETED Phase PHASE1/PHASE2
NCT02074215 Effect of Exercises Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease Status COMPLETED Phase NA
NCT02064920 Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318) Status COMPLETED Phase PHASE2
NCT02063269 Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles Status UNKNOWN Phase NA
NCT02061878 A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02054208 Safety and Exploratory Efficacy Study of NEUROSTEM® Versus Placebo in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT02051608 A Study of Gantenerumab in Participants With Mild Alzheimer Disease Status COMPLETED Phase PHASE3
NCT02051335 Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults Status COMPLETED Phase PHASE1
NCT02051244 Measurement of Retinal Nerve Fiber Layer Thickness - a Biomarker for the Early Detection of Alzheimer's Disease? Status UNKNOWN Phase N/A
NCT02035982 Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease Status COMPLETED Phase PHASE3